Focused on tomorrow to deliver better cancer care today.

At Oncocyte, we believe that empowering physicians with bold and innovative diagnostic solutions may lead to better outcomes for their patients.

Serving Doctors and Patients

Unfortunately, cancer is a leading cause of death in the United States. Each and every year, employers, insurance companies, taxpayer-funded programs, and patients and their families spend more than 150 billion dollars on cancer-related health care.1 Yet despite the availability of more advanced screening methods and treatments, we are still fighting a losing battle. This is particularly true for lung cancer, for which survival rates have not significantly improved in more than 50 years.2

We imagine a better future.
Oncocyte is a molecular diagnostics company with a mission to provide actionable answers to physicians and patients at critical decision points across the cancer care continuum. Our goal is to provide tests and solutions that may help diagnosis and treatment, leading to improved patient outcomes and reducing the overall cost of care.

Our Team

Leadership

Ronald Andrews

President & CEO

MITCH LEVINE

Chief Financial Officer

LYNDAL HESTERBERG PH.D.

Chief Scientific Officer

Al
Parker

Chief Operating Officer

PADMA SUNDAR

Senior Vice President, Marketing & Market Access

DR. KIM DICKINSON

Vice President, Clinical Operations

We believe in the power of possibilities. Do you?

We are looking for dedicated individuals to help us bring innovative solutions to physicians and patients.

Please send your resume to careers@oncocyte.com if you would like to be part of this growing and dynamic team.

Meet Our

Scientific & Medical
Advisors

DAVID
GANDARA,

MD

THOMAS
BAUER

MD

D. KYLE
HOGARTH,

MD, FCCP

EDWAR
F. PATZ JR.

MD

ANIL
VACHANI

MD

Our
laboratory

Oncocyte’s laboratory located in Brisbane, CA holds a CLIA Certificate of Accreditation from the Centers for Medicare & Medicaid Services (CMS). Oncocyte also holds clinical laboratory licenses from California and 48 other U.S. states.

June 24-27, 2020
06/24/2020 - Western Thoracic Surgical Association (WTSA)
Details
October 17-21, 2020
10/17/2020 - CHEST Annual Meeting
Details
October 30-31, 2020
10/30/2020 - International Thoracic Surgical Oncology Summit
Details
November 10-15, 2020
11/10/2020 - Society for Immunotherapy of Cancer
Details

Contact Us

References

1. National Cancer Institute. Cancer Prevalence and Cost of Care Projections. Accessed October 17, 2019 from costprojections.cancer.gov.

2. American Cancer Society. Cancer Facts & Figures 2017. Atlanta: American Cancer Society; 2017.